Entrada Therapeutics (NASDAQ:TRDA) Sets New 1-Year High – Here’s What Happened

Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $21.77 and last traded at $21.77, with a volume of 7750 shares traded. The stock had previously closed at $21.59. Analyst Upgrades and Downgrades A number of research […]

Leave a Reply

Your email address will not be published.

Previous post Amazon.com (NASDAQ:AMZN) Stock Price Expected to Rise, Roth Mkm Analyst Says
Next post Piper Sandler Companies (NYSE:PIPR) Sets New 12-Month High – Should You Buy?